Literature DB >> 10671499

Gbetagamma-dependent phosphoinositide 3-kinase activation in hearts with in vivo pressure overload hypertrophy.

S V Naga Prasad1, G Esposito, L Mao, W J Koch, H A Rockman.   

Abstract

Activation of phosphoinositide 3-kinases is coupled to both phosphotyrosine/growth factor and G protein-coupled receptors. We explored the role of phosphoinositide 3-kinase activation in myocardium during in vivo pressure overload hypertrophy in mice. Cytosolic extracts from wild type hypertrophied hearts showed a selective increase in the phosphoinositide 3-kinase gamma isoform. To address the role of G protein-coupled receptor-mediated activation of phosphoinositide 3-kinase, we used transgenic mice with cardiac-specific overexpression of a Gbetagamma sequestering peptide. Extracts from hypertrophied transgenic hearts showed complete loss of phosphoinositide 3-kinase activation, indicating a Gbetagamma-dependent process. To determine the class of G proteins that contribute Gbetagamma dimers for in vivo phosphoinositide 3-kinase activation, two strategies were used: 1) transgenic mice with cardiac-specific overexpression of a G(q) inhibitor peptide and 2) pertussis toxin treatment prior to pressure overload in wild type mice. Pressure overloaded G(q) inhibitor transgenic mice showed a complete absence of phosphoinositide 3-kinase activation, whereas pretreatment with pertussis toxin showed robust phosphoinositide 3-kinase activation. Taken together, these data demonstrate that activation of the phosphoinositide 3-kinase during in vivo pressure overload hypertrophy is Gbetagamma-dependent and the Gbetagamma dimers arise from stimulation of G(q)-coupled receptors.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10671499     DOI: 10.1074/jbc.275.7.4693

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  47 in total

Review 1.  Mixed signals in heart failure: cancer rules.

Authors:  Masahiko Hoshijima; Kenneth R Chien
Journal:  J Clin Invest       Date:  2002-04       Impact factor: 14.808

Review 2.  Specific PI3K isoform modulation in heart failure: lessons from transgenic mice.

Authors:  Alessandra Ghigo; Fulvio Morello; Alessia Perino; Federico Damilano; Emilio Hirsch
Journal:  Curr Heart Fail Rep       Date:  2011-09

3.  A conceptual paradox of MIBG uptake in heart failure: retention with incontinence!

Authors:  Jagat Narula; Kunal Sarkar
Journal:  J Nucl Cardiol       Date:  2003 Nov-Dec       Impact factor: 5.952

Review 4.  Regulation of β-adrenergic receptor function: an emphasis on receptor resensitization.

Authors:  Neelakantan T Vasudevan; Maradumane L Mohan; Shyamal K Goswami; Sathyamangla V Naga Prasad
Journal:  Cell Cycle       Date:  2011-11-01       Impact factor: 4.534

Review 5.  Nuclear and mitochondrial signalling Akts in cardiomyocytes.

Authors:  Shigeki Miyamoto; Marta Rubio; Mark A Sussman
Journal:  Cardiovasc Res       Date:  2009-03-11       Impact factor: 10.787

6.  Unique microRNA profile in end-stage heart failure indicates alterations in specific cardiovascular signaling networks.

Authors:  Sathyamangla V Naga Prasad; Zhong-Hui Duan; Manveen K Gupta; Venkata Suresh K Surampudi; Stefano Volinia; George A Calin; Chang-Gong Liu; Ashwin Kotwal; Christine S Moravec; Randall C Starling; Dianne M Perez; Subha Sen; Qingyu Wu; Edward F Plow; Carlo M Croce; Sadashiva Karnik
Journal:  J Biol Chem       Date:  2009-07-29       Impact factor: 5.157

7.  Differential role of PI3K/Akt pathway in the infarct size limitation and antiarrhythmic protection in the rat heart.

Authors:  Tána Ravingerová; Jana Matejíková; Jan Neckár; Eva Andelová; Frantisek Kolár
Journal:  Mol Cell Biochem       Date:  2006-10-03       Impact factor: 3.396

8.  Short-term akt activation in cardiac muscle cells improves contractile function in failing hearts.

Authors:  Ichiro Shiojima; Stephan Schiekofer; Jochen G Schneider; Kurt Belisle; Kaori Sato; Martin Andrassy; Gennaro Galasso; Kenneth Walsh
Journal:  Am J Pathol       Date:  2012-09-30       Impact factor: 4.307

9.  Disruption of coordinated cardiac hypertrophy and angiogenesis contributes to the transition to heart failure.

Authors:  Ichiro Shiojima; Kaori Sato; Yasuhiro Izumiya; Stephan Schiekofer; Masahiro Ito; Ronglih Liao; Wilson S Colucci; Kenneth Walsh
Journal:  J Clin Invest       Date:  2005-08       Impact factor: 14.808

10.  NO triggers RGS4 degradation to coordinate angiogenesis and cardiomyocyte growth.

Authors:  Irina M Jaba; Zhen W Zhuang; Na Li; Yifeng Jiang; Kathleen A Martin; Albert J Sinusas; Xenophon Papademetris; Michael Simons; William C Sessa; Lawrence H Young; Daniela Tirziu
Journal:  J Clin Invest       Date:  2013-04       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.